Angiotensin pathways under therapy with empagliflozin in patients with chronic heart failure

AIMS: Large outcome studies demonstrated a reduction of heart failure hospitalization or cardiovascular death in patients with chronic heart failure (CHF). The renin–angiotensin system (RAS) is a key player in fluid and sodium regulation. The classic angiotensin‐converting enzyme–angiotensin II–angi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosch, Agnes, Poglitsch, Marko, Kannenkeril, Dennis, Kolwelter, Julie, Striepe, Kristina, Ott, Christian, Rauh, Manfred, Schiffer, Mario, Achenbach, Stephan, Schmieder, Roland E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192237/
https://www.ncbi.nlm.nih.gov/pubmed/36782339
http://dx.doi.org/10.1002/ehf2.14313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192237/
https://www.ncbi.nlm.nih.gov/pubmed/36782339
http://dx.doi.org/10.1002/ehf2.14313

Ejemplares similares